Color Doppler sonography in Graves' disease: Value in assessing activity of disease and predicting outcome

American Journal of Roentgenology

Volumn 166, Issue 1, 1996, Pages 203-207

  Castagnone, Daniela ^a   Rivolta, Roberto ^a   Rescalli, Stefania ^a   Baldini, Marina I ^b   Tozzi, Roberta ^b   Cantalamessa, Luigi ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ACTIVITY; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

EID: 0030045898     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.166.1.8571877     Document Type: Article

References (14)

1. Hodgson KJ, Lazarus JH, Wheeler MH, et al Duplex scan-derived thyroid blood flow in euthyroid and hyperthyroid patients. World J Surg 1988;12.470-475
2. Arntzenius AB, Smit LJ, Schipper J, Van Der Heide D, Meinders AE. Inverse relation between iodine intake and thyroid blood flow, color doppler flow imaging in euthyroid humans. J Clin Endocrinol Metab 1991; 73:1051-1055
3. Tegler L, Giilquist J, Anderberg B, Lundstrom B, Johansson H. Thyroid Wood flow rate in man electromagnetic flowmetry during operation in euthyroid normal gland, nontoxic goiter, and hyperthyroidism J Endocrinol Invest 1981,4:335-341
4. Rails PW, Mayekawa DS, Lee KP, et al. Color-flow doppler sonography in Graves disease: "thyroid inferno" AJR 1988;150:781-784
5. Brown MC, Spencer R. Thyroid gland volume estimated by use of ultra-sound in addition to scintigraphy Acta Radiol (Oncol) 1978;17.37-41
6. Berry CC. A tutorial on confidence intervals for proportions in diagnostic radiology. AJR 1990;154 477-480
7. Schleusener H, Schwander J, Fisher C, et al. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1989;120:689-701
8. Takamatsu J, Kuma K, Mozai T. Serum triiodothyronine to thyroxine ratio. a newly recognized predictor of the outcome of hyperthyroidism due to Graves' disease. J Clin Endocrinol Metab 1986;62.980-983
9. Yamada T, Koizumi Y, Sato A, et al. Reappraisal of the 3,5,3'-triiodothyronine suppression test in the prediction of long-term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. J Clin Endocrinol Metab 1984;58:676-680
10. Hamada N, Ito K, Mimura T, et al. Retrospective revaluation of the significance of thyroid microsomal antibody in the treatment of Graves' disease. Acta Endocrinol (Copenh) 1987;114:328-335
11. McGregor AM, Smith BR, Hall R, Petersen MM, Miller M, Dewar PJ Prediction of relapse in hyperthyroid Graves' disease. Lancet 1980;1:1101-1103
12. Garcia-Mayor RVG, Paramo C, Luna Cano R, Perez Mendez LF, Galofre JC, Andrade A Antithyroid drug and Graves' hyperthyroidism: significance of treatment duration and TRAb determination on lasting remission. J Endocrinol Invest 1992,15:815-820
13. Wilson R, McKillop JH, Henderson N, Pearson DX, Thompson JA. The ability of serum receptor activity (TRAb) and HLA status to predict remission of thyrotoxicosis following medical therapy for Graves' disease. Clin Endocrinol (Oxf) 1986;25:151-156
14. Vitti P, Rago T, Mancusi F, et al. Thyroid hypoechogenic pattern at ultra-sonography as a tool for predicting recurrence of hyperthyroidism after medical treatment in patients with Graves' disease. Acta Endocrinol (Copenh) 1992;126:128-131